Bylantra (devimistat)

News alerts, weekly reports and conference planners

Company:

Cornerstone Pharma, Ono Pharma

Drug class:

PDH inhibitor, α-KGDH inhibitor

Related drugs:

‹

›

No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	devimistat Sensitive: B - Late Trials devimistat Sensitive : B	devimistat Sensitive: B - Late Trials devimistat Sensitive : B
No biomarker	Pancreatic Cancer	No biomarker	Pancreatic Cancer	devimistat Sensitive: B - Late Trials devimistat Sensitive : B	devimistat Sensitive: B - Late Trials devimistat Sensitive : B

Associations
(2)